Integrable Magnetic Fluid Hyperthermia Systems for 3D Magnetic Particle Imaging

TL;DR

This paper presents an integrated magnetic fluid hyperthermia platform compatible with commercial magnetic particle imaging systems, enabling localized hyperthermia and imaging-guided therapy without system transfer or interference.

Contribution

The authors develop and evaluate a self-compensating, integrable MFH platform that extends existing MPI scanners with hyperthermia capabilities, addressing magnetic coupling issues.

Findings

The platform generates effective magnetic fields for particle heating.

It is compatible with commercial MPI scanners and allows spatially selective hyperthermia.

The system demonstrates safe magnetic coupling and cooling capabilities.

Abstract

Background: Combining magnetic particle imaging (MPI) and magnetic fluid hyperthermia (MFH) offers the ability to perform localized hyperthermia and magnetic particle imaging-assisted ther-mometry of hyperthermia treatment. This allows precise regional selective heating inside the body without invasive interventions. In current MPI-MFH platforms, separate systems are used, which require object transfer from one system to another. Here, we present the design, development and evaluation process for integrable MFH platforms, which extends a commercial MPI scanner with the functionality of MFH. Methods: The biggest issue of integrating magnetic fluid hyperthermia platforms into a magnetic par-ticle imaging system is the magnetic coupling of the devices, which induces high voltage in the imaging system, and is harming its components. In this paper we use a self-compensation approach derived from heuristic algorithms to protect the magnetic particle imaging scanner. The integrable platforms are evaluated regarding electrical and magnetic characteristics, cooling capability, field strength, the magnetic coupling to a replica of the magnetic particle imaging system's main solenoid and particle heating. Results: The MFH platforms generate suitable magnetic fields for magnetic heating of particles and are compatible with a commercial magnetic particle imaging scanner. In combination with the imaging system, selective heating with a gradient field and steerable heating positioning using the MPI focus fields are possible. Conclusion: The proposed MFH platforms serve as a therapeutic tool to unlock MFH functionality of a commercial magnetic particle imaging scanner, enabling its use in future preclinical trials of MPI-guided, spatially selective magnetic hyperthermia therapy.